AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in AN2 Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- +3 vs. Q4 2023
- Shares held
- 18.7M
- −1.66M (−8.1%) vs. Q4 2023
- Total value
- $60.9M
- −$357.0M (−85.4%) vs. Q4 2023
- New holders
- 18
- 13 more added
- Sold out
- 15
- 16 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 128 | $416 | 0.00% | +2+1.6% | Added |
| Federated Hermes, Inc. | 211 | $686 | 0.00% | −47−18.2% | Reduced |
| Rhumbline Advisers | 250 | $812 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 300 | $975 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,113 | $3.62K | 0.00% | +1,050+1,666.7% | Added |
| Morgan Stanley | 4,164 | $13.5K | 0.00% | +833+25.0% | Added |
| California State Teachers Retirement System | 9,251 | $30.1K | 0.00% | +9,251 | New |
| Clear Street Markets LLC | 10,000 | $33.0K | 0.02% | +10,000 | New |
| Atom Investors LP | 11,905 | $38.7K | 0.00% | +11,905 | New |
| Bank of America Corp | 14,972 | $48.7K | 0.00% | −6,922−31.6% | Reduced |
| Chicago Partners Investment Group LLC | 22,001 | $52.1K | 0.00% | +22,001 | New |
| UBS Group AG | 19,574 | $63.6K | 0.00% | +19,574 | New |
| Swiss National Bank | 20,575 | $66.9K | 0.00% | +20,575 | New |
| Private Advisor Group, LLC | 22,500 | $73.1K | 0.00% | +22,500 | New |
| HRT Financial LP | 24,366 | $79.0K | 0.00% | +24,366 | New |
| Bridgeway Capital Management, LLC | 26,292 | $85.4K | 0.00% | −10,700−28.9% | Reduced |
| Credit Suisse AG | 26,630 | $86.5K | 0.00% | +26,630 | New |
| Barclays PLC | 28,318 | $92.0K | 0.00% | −15,920−36.0% | Reduced |
| Goldman Sachs Group Inc | 28,370 | $92.2K | 0.00% | +14,324+102.0% | Added |
| Captrust Financial Advisors | 28,667 | $93.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 36,363 | $118.2K | 0.00% | +3,313+10.0% | Added |
| Occudo Quantitative Strategies LP | 37,697 | $122.5K | 0.02% | +37,697 | New |
| Dimensional Fund Advisors LP | 38,115 | $123.9K | 0.00% | +38,115 | New |
| XTX Topco Ltd | 38,666 | $125.7K | 0.02% | +38,666 | New |
| Prelude Capital Management, LLC | 40,300 | $131.0K | 0.01% | +40,300 | New |
| Laurion Capital Management LP | 43,814 | $142.4K | 0.00% | 00.0% | Unchanged |
| RMB Capital Management, LLC | 45,942 | $149.3K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 49,607 | $161.2K | 0.00% | +49,607 | New |
| Qube Research & Technologies Ltd | 50,365 | $163.7K | 0.00% | −21,843−30.3% | Reduced |
| Jane Street Group, LLC | 59,166 | $192.3K | 0.00% | −279−0.5% | Reduced |
| State Street Corp | 60,302 | $196.0K | 0.00% | +22,000+57.4% | Added |
| Citigroup Inc | 70,807 | $230.1K | 0.00% | −89,679−55.9% | Reduced |
| UBS Asset Management Americas Inc | 76,200 | $247.7K | 0.00% | +76,200 | New |
| Marshall Wace, LLP | 82,498 | $268.1K | 0.00% | −254,823−75.5% | Reduced |
| Two Sigma Investments, LP | 94,168 | $306.0K | 0.00% | +74,920+389.2% | Added |
| Millennium Management LLC | 96,914 | $315.0K | 0.00% | +57,240+144.3% | Added |
| Nantahala Capital Management, LLC | 98,278 | $319.4K | 0.03% | −150,000−60.4% | Reduced |
| Alyeska Investment Group, L.P. | 100,000 | $325.0K | 0.00% | +50,000+100.0% | Added |
| Walleye Capital LLC | 132,787 | $431.6K | 0.00% | +132,787 | New |
| Acadian Asset Management LLC | 163,496 | $529.0K | 0.00% | +163,496 | New |
| Geode Capital Management, LLC | 179,370 | $583.1K | 0.00% | +747+0.4% | Added |
| Susquehanna International Group, LLP | 202,850 | $659.3K | 0.00% | +103,446+104.1% | Added |
| Ghost Tree Capital, LLC | 219,331 | $712.8K | 0.23% | +219,331 | New |
| BlackRock Inc. | 291,086 | $946.0K | 0.00% | −14,755−4.8% | Reduced |
| Adage Capital Partners GP, L.L.C. | 312,615 | $1.02M | 0.00% | −588,057−65.3% | Reduced |
| Vanguard Group Inc | 1,047,769 | $3.41M | 0.00% | −4,822−0.5% | Reduced |
| Octagon Capital Advisors LP | 1,103,000 | $3.58M | 0.44% | +438,425+66.0% | Added |
| Avidity Partners Management LP | 1,150,000 | $3.74M | 0.13% | +10,000+0.9% | Added |
| Janus Henderson Group PLC | 1,221,145 | $3.98M | 0.00% | −58,830−4.6% | Reduced |
| BVF Inc | 1,239,470 | $4.03M | 0.11% | −324,493−20.7% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,388,889 | $4.51M | 0.19% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 1,555,118 | $5.05M | 0.40% | −1,123,091−41.9% | Reduced |
| Citadel Advisors LLC | 1,556,554 | $5.06M | 0.00% | −2880.0% | Reduced |
| Ra Capital Management, L.P. | 5,551,295 | $18.0M | 0.23% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −187,399−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −157,891−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −132,000−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −51,660−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −39,472−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −33,997−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −25,842−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −25,800−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −19,285−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −18,337−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −16,483−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −13,392−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −9,842−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −670−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −621−100.0% | Sold out |